Top Markets
Coin of the day
Arch Therapeutics, Inc. Arch Therapeutics, Inc.

Arch Therapeutics, Inc.

ARTH
Rankning i aktier #42478
Arch Therapeutics, Inc., operating alongside its affiliated companies,... Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease. Its leading products, the AC5 advanced wound system and the AC5 topical hemostat, are specifically designed for application on the skin, proving effective for managing intricate chronic wounds or acute surgical injuries. The company was established in 2006 and is headquartered in Framingham, Massachusetts.
Aktiekurs
$0.0009
Senast synkroniserad: 2025-05-27
Marknadsvärde
$1.15K
Förändring (1 dag)
0.00%
Förändring (1 år)
0.00%
Land
US
Handel Arch Therapeutics, Inc. (ARTH)

Kategori

EPS för Arch Therapeutics, Inc. (ARTH)
EPS per June 2024 TTM: $-2.86
Enligt Arch Therapeutics, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-2.86. Vid slutet av 2022 hade bolaget ett EPS på $-3.56, en minskning jämfört med EPS från 2021 som var $-5.97.
EPS-historik för Arch Therapeutics, Inc. från 2011 till 2026
EPS vid slutet av varje år
År EPS Ändra
2026 (TTM) $-2.86 25.99%
2023 $-2.27 -36.24%
2022 $-3.56 -40.37%
2021 $-5.97 39.81%
2020 $-4.27 30.58%
2019 $-3.27 -48.10%
2018 $-6.30 -42.25%
2017 $-10.91 10.54%
2016 $-9.87 36.33%
2015 $-7.24 -70.00%
2014 $-24.13 114.11%
2013 $-11.27 766.92%
2012 $-1.30 1,424.03%
2011 $-0.09 0.00%
EPS för liknande företag eller konkurrenter
Företag EPS EPS-differens Land
$17.32 -705.59%
US
$27.74 -1,069.93%
NL
- -
CH
$13.70 -579.02%
BE
- -
KR